Acetazolamide
 OpenBabel02212023462D

 13 13  0  0  0  0  0  0  0  0999 V2000
    1.2822    3.1768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2822    2.3518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9967    1.9393    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5678    1.9393    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5678    1.1143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2352    0.6294    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9803   -0.1553    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1553   -0.1553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0997    0.6294    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3297   -0.8227    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8146   -1.4901    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9971   -0.3378    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3378   -1.3076    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  2  0  0  0  0
  2  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  2  0  0  0  0
  5  9  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  8 10  1  0  0  0  0
 10 11  2  0  0  0  0
 10 12  2  0  0  0  0
 10 13  1  0  0  0  0
M  END
>  <CdId>
459

>  <Mol Weight>
222.245

>  <Formula>
C4H6N4O3S2

>  <ID>
T0813

>  <Name>
Acetazolamide

>  <Synonyms>
Diamox

>  <CAS>
59-66-5

>  <Approved status>
FDA

>  <Disease>
Nervous system

>  <Indication>
Glaucoma; ?Epileptic Seizure; ?Idiopathic Intracranial Hypertension; ?Altitude Sickness; ?Cystinuria; ?Periodic Paralysis; ?Central Sleep Apnea; Dural Ectasia

>  <Pathways>
Metabolism

>  <Target>
Carbonic Anhydrase inhibitor

>  <Receptor>
Carbonic anhydrase

$$$$
